Social Media Ideas for Agents.md

Agent-based modeling demonstrates how target-independent processes supplement killing by antibody-drug conjugates in can...

by Melissa C. Calopiz, Jennifer J. Linderman, Greg M. Thurber Antibody-drug conjugates (ADCs) have had remarkable clinical success in recent years with multiple new approvals. How...

@ant-design/cli — A fully offline CLI for Ant Design component knowledge, project analysis, and version migration (with...

Comments

SFM

SFM Anonymous (not verified) Wed, 06/10/2026 - 20:50 field_thread_url https://cafepharma.com/boards/threads/sfm.701491/ board name...

Shield - AE

Shield - AE Anonymous (not verified) Sat, 06/20/2026 - 23:59 field_thread_url https://cafepharma.com/boards/threads/shield-ae.709735/ bo...

SFM

SFM Anonymous (not verified) Sun, 06/14/2026 - 20:54 field_thread_url https://cafepharma.com/boards/threads/sfm.701491/ board name...

ADC Therapeutics

ADC Therapeutics Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/adc-therapeutics.665008/...

Shield - AE

Shield - AE Anonymous (not verified) Fri, 06/26/2026 - 03:02 field_thread_url https://cafepharma.com/boards/threads/shield-ae.709735/ bo...

ANC

ANC Anonymous (not verified) Thu, 06/04/2026 - 17:44 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...

How to Add Drug Interaction Checking to Your Health App in 5 Minutes

Nearly 1 in 4 Americans takes a prescription drug alongside a dietary supplement. That's roughly 75 million people who might not know that their fish oil could be amplifying their...

May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer

May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer admin Thu, 05/28/2026 - 11:51 Steady progress across the board today, with new appro...

Analytical Challenges for Antibody-Drug Conjugate (ADC) Manufacturing

This collection of articles and expert perspectives explores the critical challenges shaping ADC development today, from analytical strategy and impurity control to linker technolo...

<![CDATA[FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report ]]>

<![CDATA[Pharmaceutical Executive: June 2026 Interactive Digital Edition]]>

Building a Scaffold-Split Random Forest QSAR Co-Scientist for EGFR Inhibitor Discovery Using ChEMBL, RDKit, SHAP, and BR...

In this tutorial, we build an autonomous AI co-scientist for EGFR C797S inhibitor discovery. We resolve the target through ChEMBL and UniProt, then mine IC50 records into a clean p...

<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...

Agent's Design — design resources built for Cursor, Claude Code, Codex, v0, Bolt & Lovable

Stop shipping the same AI-generated UI If you use Cursor, Claude Code, Codex, v0, Bolt, or Lovable, you've seen it: Inter everywhere purple-to-indigo gradients generic "hero +...

Anthropic Launches Claude Science Beta: A Multi-Agent AI Workbench for Reproducible Genomics, Proteomics, and Cheminform...

Anthropic released Claude Science in beta on June 30, 2026. The app runs on existing Claude models. A coordinating agent delegates to domain specialists, a reviewer agent flags and...

— Егор, а можешь показать свой AGENTS.md?

Да не вопрос! На самом деле буквально три месяца назад у меня вообще не было никакого AGENTS.md. Он появился автоматом, когда я устанавливал code-review-graph.История такая: я кажд...

<![CDATA[Help Shape the Future of Responsible AI]]>

Omnistar

This Software-as-a-Service helps medical research charities and health funders manage the full grant lifecycle – from open calls, peer review and rebuttals through to project overs...

BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows

BMS is the latest large pharma company to make a major bet on AI, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared intelligence platform”...

Multi-metal cooperation drives lung cancer chemoresistance, reversed by MiADMSA

In the unending war against cancer, few adversaries have proven as stubbornly resilient as chemoresistance in lung malignancies. For decades, oncologists have watched with frustrat...